These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30278435)

  • 1. Liver Maximum Capacity: A Novel Test to Accurately Diagnose Different Stages of Liver Fibrosis.
    Buechter M; Thimm J; Baba HA; Bertram S; Willuweit K; Gerken G; Kahraman A
    Digestion; 2019; 100(1):45-54. PubMed ID: 30278435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
    Afify SM; Tabll A; Nawara HM; El Kassas M; Elfert A; Seno M; El-Kousy S
    Clin Lab; 2018 Oct; 64(10):1685-1693. PubMed ID: 30336529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
    Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
    World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
    Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
    World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive structure-function assessment of the liver by 2D time-harmonic elastography and the dynamic Liver MAximum capacity (LiMAx) test.
    Heucke N; Wuensch T; Mohr J; Kaffarnik M; Arsenic R; Sinn B; Müller T; Pratschke J; Stockmann M; Sack I; Tzschätzsch H
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1611-1619. PubMed ID: 30756433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
    Deghady A; Abdou A; El-Neanaey WA; Diab I
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
    Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
    Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
    Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
    Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic liver function measured by LiMAx - a reliable diagnostic and prognostic tool in chronic liver disease.
    Buechter M; Kersting S; Gerken G; Kahraman A
    Sci Rep; 2019 Sep; 9(1):13577. PubMed ID: 31537822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure.
    Hukkinen M; Kivisaari R; Lohi J; Heikkilä P; Mutanen A; Merras-Salmio L; Pakarinen MP
    Liver Int; 2016 Mar; 36(3):361-9. PubMed ID: 26058319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.